Questions to Ask Before Ordering From a New Peptide Vendor
A practical checklist of questions to ask before ordering from a new peptide vendor, covering documentation, listing conventions, and how supply moves.
Diana Walsh, PharmD, BCPS is a Board-Certified Pharmacotherapy Specialist with a Doctor of Pharmacy from the University of Minnesota and pharmacy residency training at Mayo Clinic.
Before placing a first order with an unfamiliar supplier, there are a handful of questions to ask before ordering from a new peptide vendor that separate a well-documented listing from a guess dressed up as a product page. The answers show up in how a listing is written, what paperwork is offered without being asked for twice, and whether the numbers on the page hold together under basic arithmetic. None of this requires insider knowledge of a supplier’s operations — it requires reading the listing the way a reviewer would.
What documentation should accompany the product
The first question is whether a certificate of analysis (COA) is available per batch, not just per product line. A COA tied to a specific lot number means the vendor is testing what actually shipped, rather than publishing a representative result from an earlier run and reusing it indefinitely. Ask when the COA was issued and whether the lot number on the vial or bag matches the lot number on the document. A mismatch, or a COA with no lot number at all, is a documentation gap worth noting before anything else.
A second layer worth asking about is what testing method produced the COA — high-performance liquid chromatography (HPLC) and mass spectrometry are the two most commonly cited, and a listing that names the method and the testing lab is giving a reviewer something to check. A listing that only says “third-party tested” without naming who did the testing is asking for trust without giving a way to verify it.
How is purity and concentration actually reported
Purity figures on a listing page should be legible as a single number with a stated method, not a range presented as a guarantee. A listing that reports “99%+” without a COA attached is a claim, not a documented result. Concentration, separately, describes how much peptide mass is present per unit of solution once reconstituted — it is a property of the mixed vial, not the lyophilized powder, and a listing that conflates the two is worth a second look.
Here is a worked example of how concentration is calculated, since the arithmetic is simple but frequently glossed over on listing pages: a vial labeled 5 mg reconstituted with 2 mL of bacteriostatic water yields a concentration of 5 mg ÷ 2 mL = 2.5 mg/mL. Converted to a per-100-unit insulin syringe reading, where 1 mL equals 100 units, that same 2.5 mg/mL solution puts 2.5 mg across a full 100-unit draw, or 0.025 mg (25 mcg) per unit drawn. A listing or a vendor’s support answer that gets this kind of conversion wrong, or refuses to walk through it, is a signal about how carefully the rest of the catalogue was put together. A calculator reference such as peptcalc.com can be used to check this kind of reconstitution math independently of what a vendor states.
Comparing what a listing states versus what it omits
The table below separates the categories worth checking against what a typical listing actually discloses.
| Category | What a complete listing states | Common omission |
|---|---|---|
| Identity | Peptide name, sequence or CAS reference | Generic name only, no reference number |
| Purity | Percentage with method (HPLC, MS) | Percentage with no method named |
| COA | Per-batch, lot-matched | Single COA reused across batches |
| Storage | Lyophilized and reconstituted storage conditions | Storage instructions absent |
| Packaging | Vial size, form (lyophilized powder, solution) | Form left ambiguous |
What does the pricing structure reveal
Pricing is another place where questions to ask before ordering from a new peptide vendor pay off. A per-mg price that looks unusually low compared to listings elsewhere in the same category is not automatically wrong, but it is worth asking what accounts for the difference — batch size, packaging cost, or a shorter supply chain are all legitimate answers, while a vendor that cannot explain its own pricing at all is a weaker signal. It also helps to compare how a given catalogue’s per-vial pricing is structured across sizes, since peer research-peptide catalogs track how these figures are typically presented across vendors, which gives a baseline for what a normal spread looks like.
How is shipping and storage handled
Lyophilized peptides are generally more stable at room temperature for short periods than reconstituted solutions, which typically call for refrigeration. Ask whether the vendor ships with any temperature protection (cold packs, insulated packaging) when ambient conditions warrant it, and whether the listing states an expected transit window. A vendor that cannot answer how long a shipment typically takes, or that ships lyophilized product without any packaging appropriate to the season, is giving a preview of how the rest of the order will be handled.
What does the vendor’s catalogue breadth suggest
A vendor with a narrow, single-product catalogue is not disqualifying on its own, but a broader catalogue with consistent formatting across listings — same COA structure, same purity notation, same storage language — suggests a standardized process rather than one-off listings assembled independently. Reviewing a catalogue’s structure across many products, the way a resource like heezresearch.com/ organizes its listings, gives a sense of what consistent documentation looks like at scale, which is a useful comparison point when a new vendor’s page feels thin.
Reading the fine print on return and discrepancy policy
Finally, ask what happens if a shipment does not match its listing — wrong lot, damaged packaging, or a COA that does not correspond to what arrived. A vendor that states a clear discrepancy or return process before an order is placed, rather than only after a complaint, has already answered one of the more important questions on this list.
Summary
The questions to ask before ordering from a new peptide vendor mostly reduce to whether documentation is specific, whether the arithmetic behind concentration and pricing is checkable, and whether the catalogue is consistent across listings rather than assembled ad hoc. None of these questions require special access — they are answerable from what a listing chooses to state, and from what it leaves out.